XML 49 R31.htm IDEA: XBRL DOCUMENT
v3.25.2

STOCKHOLDERS’ EQUITY (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2025
Equity [Abstract] |
Schedule of weighted-average assumptions used to estimate the fair values of the stock options granted |
Schedule of weighted-average assumptions used to estimate the fair values of the stock options granted |  |  |  |
|  | Lunai Bioworks Inc.
Expected term (in years) |  |  | 5.5 |
Volatility |  |  | 109.45% – 118.99 | %
Risk free interest rate |  |  | 3.86%- 4.40 | %
Dividend yield |  |  | 0 | %
Schedule of stock options outstanding |
Schedule of stock options outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Options Outstanding |  |  |  | Options Exercisable
|  | Exercise Price Ranges |  | Number Outstanding |  | Weighted Average Remaining Contractual Life (years) |  | Weighted Average Exercise Price |  | Number Exercisable |  | Weighted Average Remaining Contractual Life (years) |  | Weighted Average Exercise Price
|  | $ | 0.45–4.50 |  |  |  | 4,623,614 |  |  |  | 8.97 |  |  | $ | 0.75 |  |  |  | 567,233 |  |  |  | 8.71 |  |  | $ | 0.96 |
|  | $ | 4.51–6.50 |  |  |  | — |  |  |  | — |  |  | $ | — |  |  |  | — |  |  |  | — |  |  | $ | — |
|  | $ | 6.51–12.00 |  |  |  | — |  |  |  | — |  |  | $ | — |  |  |  | — |  |  |  | — |  |  | $ | — |
Total |  |  |  |  |  |  | 4,623,614 |  |  |  | 8.97 |  |  | $ | 0.75 |  |  |  | 567,233 |  |  |  | 8.71 |  |  | $ | 0.96 |
Schedule of Stock option activity |
Schedule of Stock option activity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Shares |  | Weighted Average Exercise Price |  | Average Remaining Life |  | Weighted Average Intrinsic Value
Outstanding at June 30, 2024 |  |  | 5,527,852 |  |  | $ | 2.11 |  |  |  | 7.30 |  |  | $ | — |
Granted |  |  | 4,249,665 |  |  | $ | 0.64 |  |  |  |  |  |  |  |  |
Exercised |  |  | — |  |  | $ | — |  |  |  |  |  |  |  |  |
Forfeited |  |  | — |  |  | $ | — |  |  |  |  |  |  |  |  |
Expired/Canceled |  |  | (5,153,903 | ) |  | $ | 2.12 |  |  |  |  |  |  |  |  |
Outstanding at June 30, 2025 |  |  | 4,623,614 |  |  | $ | 0.75 |  |  |  | 8.97 |  |  | $ | — |
Exercisable at June 30, 2025 |  |  | 567,233 |  |  | $ | 0.96 |  |  |  | 8.71 |  |  | $ | — |
Schedule of common stock purchase warrants outstanding |
Schedule of common stock purchase warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Warrants Outstanding |  | Warrants Exercisable
|  |  |  |  |  | Weighted |  |  |  |  |  | Weighted |  |
|  |  |  |  |  | Average |  | Weighted |  |  |  | Average |  | Weighted
|  |  |  |  |  | Remaining |  | Average |  |  |  | Remaining |  | Average
|  | Exercise |  | Number |  | Contractual |  | Exercise |  | Number |  | Contractual |  | Exercise
|  | Price |  | Outstanding |  | Life (years) |  | Price |  | Exercisable |  | Life (years) |  | Price
|  |  | $ | 0.53 |  |  |  | 471,698 |  |  |  | 2.99 |  |  |  |  |  |  |  | 471,698 |  |  |  | 2.99 |  |  |  |  |
|  |  | $ | 0.65 |  |  |  | 741,274 |  |  |  | 3.09 |  |  |  |  |  |  |  | 741,274 |  |  |  | 3.09 |  |  |  |  |
|  |  | $ | 1.14 |  |  |  | 1,189,036 |  |  |  | 2.73 |  |  |  |  |  |  |  | 1,189,036 |  |  |  | 2.73 |  |  |  |  |
|  |  | $ | 1.47 |  |  |  | 642,128 |  |  |  | 3.96 |  |  |  |  |  |  |  | 642,128 |  |  |  | 3.96 |  |  |  |  |
|  |  | $ | 1.48 |  |  |  | 50,740 |  |  |  | 3.99 |  |  |  |  |  |  |  | 50,740 |  |  |  | 3.99 |  |  |  |  |
|  |  | $ | 0.50-1.68 |  |  |  |  |  |  |  | 3,175,00 |  |  |  | 0.65 |  |  |  | 3,175,000 |  |  |  | 0.65 |  |  |  |  |
Total |  |  |  |  |  |  |  | 6,269,876 |  |  |  | 1.88 |  |  | $ | 0.91 |  |  |  | 6,269,876 |  |  |  | 1.88 |  |  | $ | 0.91 |
Schedule of warrants outstanding |
Schedule of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |
|  | Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Life
Outstanding at June 30, 2024 |  |  | 3,094,876 |  |  | $ | 1.00 |  |  |  | 3.48 |
Granted |  |  | 3,175,000 |  |  | $ | 0.82 |  |  |  | 0.65 |
Exercised |  |  | — |  |  | $ | — |  |  |  | — |
Cancelled/Expired |  |  | — |  |  | $ | — |  |  |  | — |
Outstanding and exercisable at June 30, 2025 |  |  | 6,269,876 |  |  | $ | 0.91 |  |  |  | 1.88 |

X
- References No definition available. + Details
Name: | RENB_ScheduleOfCommonStockPurchaseWarrantsOutstandingTableTextBlock
Namespace Prefix: | RENB_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | RENB_ScheduleOfShareBasedPaymentAwardStockOptionValuationAssumptionsTableTextBlock
Namespace Prefix: | RENB_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | RENB_ScheduleOfStockBasedCompensationActivityTableTextBlock
Namespace Prefix: | RENB_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | RENB_ScheduleOfWarrantsOutstandingTableTextBlock
Namespace Prefix: | RENB_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration